These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31414547)

  • 21. Editorial: scoring systems in primary biliary cholangitis - time to make a move. Authors' reply.
    Yang F; Yang Y; Tang R; Gershwin ME; Ma X
    Aliment Pharmacol Ther; 2017 Apr; 45(8):1164-1165. PubMed ID: 28326577
    [No Abstract]   [Full Text] [Related]  

  • 22. Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann
    Kummen M; Hov JR
    Gut; 2017 Apr; 66(4):755-756. PubMed ID: 27340191
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
    Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C
    Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gut-Liver Axis in Primary Sclerosing Cholangitis: Are Pathobionts the Missing Link?
    O'Hara SP; LaRusso NF
    Hepatology; 2019 Sep; 70(3):1058-1060. PubMed ID: 31013359
    [No Abstract]   [Full Text] [Related]  

  • 25. Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of
    Rühlemann MC; Solovjeva MEL; Zenouzi R; Liwinski T; Kummen M; Lieb W; Hov JR; Schramm C; Franke A; Bang C
    Gut; 2020 Oct; 69(10):1890-1892. PubMed ID: 31653787
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: rapid assessment of health-related quality of life in primary biliary cholangitis-no excuse not to ask. Authors' reply.
    Alrubaiy L; Mells G; Flack S; Bosomworth H; Hutchings H; Williams J; Jones D
    Aliment Pharmacol Ther; 2020 Jan; 51(1):183. PubMed ID: 31850579
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise? Authors' reply.
    Tse CS; Loftus EV; Raffals LE; Gossard AA; Lightner AL
    Aliment Pharmacol Ther; 2018 Sep; 48(5):578-579. PubMed ID: 30156321
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA antigens in ulcerative colitis and primary sclerosing cholangitis.
    Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA
    APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota-mediated liver inflammation in PSC.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2019 Mar; 16(3):140-141. PubMed ID: 30705395
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?
    Karlsen TH
    Gut; 2016 Oct; 65(10):1579-81. PubMed ID: 27402486
    [No Abstract]   [Full Text] [Related]  

  • 31. Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Lemoinne S; Marteau P
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):507-508. PubMed ID: 28797907
    [No Abstract]   [Full Text] [Related]  

  • 32. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis.
    Kozik AJ; Nakatsu CH; Chun H; Jones-Hall YL
    PLoS One; 2019; 14(11):e0225079. PubMed ID: 31703107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three cases of primary sclerosing cholangitis associated with ulcerative colitis; diagnostic usefulness of magnetic resonance cholangiopancreatography.
    Oshitani N; Iimuro M; Kawashima D; Inagawa M; Sogawa M; Jinno Y; Yamagami H; Hamasaki N; Sawa Y; Hara J; Nakamura S; Matsumoto T; Seki S; Arakawa T; Kitano A; Kuroki T
    Hepatogastroenterology; 2002; 49(44):317-21. PubMed ID: 11995441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
    Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
    Poritz LS; Koltun WA
    Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses.
    Vieira-Silva S; Sabino J; Valles-Colomer M; Falony G; Kathagen G; Caenepeel C; Cleynen I; van der Merwe S; Vermeire S; Raes J
    Nat Microbiol; 2019 Nov; 4(11):1826-1831. PubMed ID: 31209308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
    O'Hara SP; Karlsen TH; LaRusso NF
    Gut; 2017 Nov; 66(11):1873-1877. PubMed ID: 28733279
    [No Abstract]   [Full Text] [Related]  

  • 39. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis.
    Broomé U; Hultcrantz R; Lefvert AK; Yi Q
    Dis Colon Rectum; 1998 Dec; 41(12):1543-9. PubMed ID: 9860336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.